Related Experiment Video

Updated: Aug 15, 2026

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Left ventricular assessment in myocardial infarction: the VALIANT registry

Adrian F Hernandez1, Eric J Velazquez, Scott D Solomon

  • 1Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA.

Archives of Internal Medicine
|October 12, 2005
PubMed

Insights

Left ventricular assessment after myocardial infarction (MI) was often missed, even in heart failure (HF) patients. Performing this evaluation improved care quality and reduced in-hospital mortality for MI patients.

Area of Science:

  • Cardiology
  • Clinical Outcomes Research
  • Healthcare Quality Improvement

Background:

  • Echocardiography and cardiac catheterization are key for evaluating left ventricular (LV) function post-myocardial infarction (MI).
  • The frequency of LV assessment and its impact on care quality in MI patients, particularly those with heart failure (HF), remains unclear.

Purpose of the Study:

  • To determine the utilization rates of echocardiography and cardiac catheterization for LV assessment in MI patients.
  • To investigate the association between LV assessment and the quality of care provided, including discharge medications and in-hospital outcomes.

Main Methods:

  • Analysis of patients from the Valsartan in Acute Myocardial Infarction (VALIANT) registry, stratified by presence (n=1423) or absence (n=3968) of heart failure (HF).
  • Comparison of LV assessment rates and baseline characteristics between HF and non-HF groups.
  • Evaluation of the link between LV assessment and discharge medications, and in-hospital outcomes using multivariable and propensity analyses.

Main Results:

  • 22.6% of HF patients and an unspecified percentage of non-HF patients did not undergo LV assessment.
  • Patients with LV assessment received guideline-recommended medications more frequently.
  • LV assessment was significantly associated with reduced in-hospital mortality in both HF (aOR 0.45) and non-HF (aOR 0.30) groups, an association persisting after excluding early deaths.

Conclusions:

  • Left ventricular assessment is underutilized in acute myocardial infarction patients, including those with heart failure.
  • Performing LV assessment is linked to improved quality of care and better in-hospital survival rates for myocardial infarction patients.
Abstract

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...